This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovations of Rebecca Cj Twells
Introduction
Rebecca Cj Twells is a notable inventor based in Thame, Oxon, GB. He has made significant contributions to the field of genetics and medicine, particularly in relation to type 1 diabetes. His work has implications for various diseases and disorders, showcasing the importance of his research in the medical community.
Latest Patents
Rebecca Cj Twells holds a patent for a novel receptor known as the "LDL-receptor related protein-3" (LRP-3). This invention includes encoding nucleic acid associated with type 1 diabetes, specifically the IDDM susceptibility gene IDDM4. The patent encompasses various aspects, including nucleic acid sequences, oligonucleotide primers and probes, polypeptides, and pharmaceutical compositions. It also outlines methods for diagnosis, prognosis, and treatment of diseases linked to the gene, such as autoimmune diseases, viral infections, and diabetes.
Career Highlights
Throughout his career, Rebecca Cj Twells has focused on groundbreaking research that addresses critical health issues. His innovative work has led to advancements in understanding the genetic factors associated with type 1 diabetes and other related conditions. His contributions have been recognized within the scientific community, marking him as a key figure in his field.
Collaborations
Rebecca has collaborated with esteemed colleagues, including John A Todd and John W Hess. These partnerships have further enhanced the impact of his research and have contributed to the development of new methodologies in the study of genetic diseases.
Conclusion
Rebecca Cj Twells is a distinguished inventor whose work in genetics has the potential to transform the understanding and treatment of various diseases. His patent on the LRP-3 receptor highlights the significance of his contributions to medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile